Clinical Trials Logo

Clinical Trial Summary

The intestinal microbiome is a microbial system that is influenced by host genetics and environmental exposures such as nutrition, stress and medications. There is a growing body of evidence indicating the significant contribution of the gut microbiome to host health and disease. Furthermore, it has been shown that exercise may modify the microbiome composition. However, important mechanistic questions related to the possible associations between exercise and the human gut microbiome remain unanswered. In this study, the investigators are using advanced state-of-the-art measurements of physical activity level and related metabolic parameters whether there is a connection between the microbiome and physical abilities in healthy participants and whether antibiotics consumption can influence host physical abilities and glycemic responses through changes induced in microbiome composition and function.


Clinical Trial Description

During all days of the study, participants will be connected to a continuous glucose monitor (CGM). In the second segment of the study, participants will be randomized into two groups: antibiotics or placebo, which will be consumed for 7 days. The third segment of the trial, participants will undergo an FMT/placebo administration for three consecutive days according to their randomization: participants who received antibiotics will receive FMT and participants who received placebo pills will receive placebo capsules in this segment as well. During the study, participants will collect stool and buccal samples which will be used for microbiota profiling. Furthermore, participants will undergo physical abilities test, anthropometric measurements, medical history questioners, blood and urine samples and Dual X-ray absorptiometry (DXA) test. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05024188
Study type Interventional
Source Assaf-Harofeh Medical Center
Contact Ilan Youngster, Dr.
Phone +972-50630119
Email youngsteri@asaf.health.gov.il
Status Not yet recruiting
Phase N/A
Start date January 20, 2022
Completion date January 20, 2023

See also
  Status Clinical Trial Phase
Terminated NCT04968951 - Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC) Early Phase 1
Withdrawn NCT03829878 - Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT) Phase 2
Completed NCT03497806 - Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiotaâ„¢ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection Phase 2
Recruiting NCT05821010 - Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis Phase 2
Not yet recruiting NCT04697550 - The Role of Microbiome in Recurrent Obesity N/A
Not yet recruiting NCT05002153 - The Role of Microbiome in Recurrent Obesity N/A